APR's stock fell more than 2%, even as securities firms projected that the company's third-quarter revenue this year would more than double compared to the same period last year. While Medicube's brand recognition is expanding centered on the United States and Europe, the strong won and logistics cost burdens were cited as factors that could slow short-term growth.

Shares Down Over 2%... Market Focus on Overseas Sales and Exchange Rates

As of the morning of the 22nd, APR (278470) was trading at 312,000 won, down 7,000 won (2.19%) from the previous trading day. Amid the stock's weakness, the market is focusing on the impact of overseas sales growth and exchange rate movements on earnings.

BK Investment & Securities: "Q3 Revenue Projected at 801.4 Billion Won, Operating Profit at 170.5 Billion Won"

BK Investment & Securities projected APR's third-quarter consolidated revenue at 801.4 billion won, a 107.6% increase compared to the same period last year. Operating profit was expected to rise 77.3% year-on-year to 170.5 billion won.

While both revenue and operating profit are expected to post high growth rates, the pace of growth is forecast to diverge. As the operating profit growth rate is estimated to lag behind revenue growth, it can be analyzed that investors should examine both top-line expansion and changes in profitability together.

Growth Driver Is Medicube... Expanding Recognition in the US and Europe

In overseas markets, the expansion of Medicube's brand recognition is at the center of growth. BK Investment & Securities expected that as brand recognition rises centered on the United States and Europe, APR's high revenue growth will continue.

However, the high proportion of overseas revenue can also translate into earnings pressure from exchange rate fluctuations. With the US and Europe accounting for about 70% of revenue, if the won continues to strengthen, the increase in overseas revenue converted into won could be limited. Taking this exchange rate impact into account, BK Investment & Securities forecast that even if third-quarter revenue rises sharply year-on-year, the growth rate compared to the previous quarter will slow.

Background of the Share Decline: Gap Between Expectations and Growth Pace, IFRS 1118 Variable

The gap between elevated market expectations and the actual pace of earnings growth was cited as a background to the recent share decline. Even for companies expected to deliver high growth, if market expectations rise faster than that, the possibility of slowing growth can weigh on the stock.

The exchange rate impact from accounting standard changes was also presented as a key variable. BK Investment & Securities analyzed that concerns over exchange rate effects reflected in operating items, related to the introduction of IFRS 1118, have been priced into recent share price movements.

European Inland Transport Costs 40% Higher Than the Americas

The logistics cost burden in Europe is also noteworthy. According to the securities firm's analysis, Europe's inland transport costs are about 40% higher than in the Americas. This means that as sales expand in the European market, rising transport and logistics costs could weigh on profitability.

Ultimately, APR is expected to sustain high growth in overseas markets, but it must also manage cost variables such as exchange rates and logistics costs. The positive trend of Medicube's expanding brand recognition in the US and Europe is being raised alongside concerns about slowing revenue growth due to the strong won.

Going forward, the key benchmarks will include not only whether the projected revenue of 801.4 billion won and operating profit of 170.5 billion won are achieved, but also how much the sales increases in the US and Europe translate into actual profit growth. Attention is focused on how the market's assessment may shift between expectations of high top-line growth and the burdens of exchange rates and logistics costs.

[This article is provided for informational purposes for investment reference and does not recommend the purchase or sale of any specific stock. Circumstances may vary depending on market conditions. Investment decisions and their consequences are the responsibility of the investor. AI provided some assistance.]